508 related articles for article (PubMed ID: 32868455)
1. Exploring cellular biochemistry with nanobodies.
Cheloha RW; Harmand TJ; Wijne C; Schwartz TU; Ploegh HL
J Biol Chem; 2020 Nov; 295(45):15307-15327. PubMed ID: 32868455
[TBL] [Abstract][Full Text] [Related]
2. Exploiting Nanobodies' Singular Traits.
Ingram JR; Schmidt FI; Ploegh HL
Annu Rev Immunol; 2018 Apr; 36():695-715. PubMed ID: 29490163
[TBL] [Abstract][Full Text] [Related]
3. Application Progress of the Single Domain Antibody in Medicine.
Tang H; Gao Y; Han J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
[TBL] [Abstract][Full Text] [Related]
4. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
Ji F; Ren J; Vincke C; Jia L; Muyldermans S
Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
[TBL] [Abstract][Full Text] [Related]
5. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
[TBL] [Abstract][Full Text] [Related]
7. Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.
Bakherad H; Farahmand M; Setayesh N; Ebrahim-Habibi A
Life Sci; 2020 Sep; 257():118052. PubMed ID: 32634431
[TBL] [Abstract][Full Text] [Related]
8. Camelid nanobodies: killing two birds with one stone.
Desmyter A; Spinelli S; Roussel A; Cambillau C
Curr Opin Struct Biol; 2015 Jun; 32():1-8. PubMed ID: 25614146
[TBL] [Abstract][Full Text] [Related]
9. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
Jin BK; Odongo S; Radwanska M; Magez S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
[TBL] [Abstract][Full Text] [Related]
10. Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
Lafaye P; Li T
Comp Immunol Microbiol Infect Dis; 2018 Oct; 60():17-22. PubMed ID: 30396425
[TBL] [Abstract][Full Text] [Related]
11. A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies.
Pleiner T; Bates M; Görlich D
J Cell Biol; 2018 Mar; 217(3):1143-1154. PubMed ID: 29263082
[TBL] [Abstract][Full Text] [Related]
12. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
[TBL] [Abstract][Full Text] [Related]
13. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
14. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
15. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
[TBL] [Abstract][Full Text] [Related]
16. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
17. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
[TBL] [Abstract][Full Text] [Related]
18. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
De Groof TWM; Bobkov V; Heukers R; Smit MJ
Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics.
Mir MA; Mehraj U; Sheikh BA; Hamdani SS
Hum Antibodies; 2020; 28(1):29-51. PubMed ID: 31322555
[TBL] [Abstract][Full Text] [Related]
20. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
